La Jolla, CA (PRWEB) October 24, 2013
WHAT: A roundtable co-hosted by NEHI and the California Healthcare Institute will explore how comparative effectiveness research is evolving in unexpected ways, with a new focus on patient outcomes fueled by the potential, and the challenges, of using Big Data and Real World Evidence to prove what works for whom.
OBJECTIVE: To provide clarity on the impact of future CER on the adoption of valuable health care innovations and to explore how major stakeholders can reach consensus on creating patient-centered research that will send clear signals to innovators throughout the health care system. New research on how current and projected federal CER dollars are being spent will be released.
WHO: Two distinguished panels of national experts representing payers, providers, patients and industry including:
> Anne Beal, MD, PCORI
> Marc Boutin, National Health Council
> John Castellani, PhRMA
> Sharon Levine, MD, The Permanente Medical Group
> Theodore Lystig, PhD, Medtronic
> Alan Rosenberg, MD, WellPoint
> Michael Rosenblatt, MD, Merck
> Jean Slutsky, AHRQ
> Clifford Goodman, PhD, The Lewin Group
WHEN: Tuesday, October 29, 2013; 12:30-4:30 PM
WHERE: National Press Club, Ballroom, 529 14th Street NW, Washington, DC
MEDIA ACCESS: To RVSP or schedule media interviews please contact Nick King of NEHI at nking(at)nehi(dot)net, 617-225-0857 or Erica Hiar of CHI at hiar(at)chi(dot)org, 202-974-6322.
About NEHI
NEHI is a national health policy institute focused on enabling innovation to improve health care quality and lower health care costs. In partnership with members from all across the health care system, NEHI conducts evidence-based research and stimulates policy change to improve the quality and the value of health care. Together with this unparalleled network of committed health care leaders, NEHI brings an objective, collaborative and fresh voice to health policy. For more information, visit http://www.nehi.net. Follow us on Twitter at @NEHI_News.
About CHI:
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.